Sign in to continue:

Monday, March 2nd, 2026

Pacific Radiance Ltd. 2025 Full Year Financial Results: Strong Revenue Growth and Proposed Final Dividend of 0.175 SGD Cents per Share

Pacific Radiance Ltd. FY2025 Financial Review: Strong Revenue Growth and Improved Profitability Amid Market Volatility

Pacific Radiance Ltd., a Singapore-listed provider of offshore support and shipyard services, reported robust results for the year ended 31 December 2025. The Group delivered significant revenue and profitability gains, despite a challenging global macroeconomic and geopolitical backdrop.

Key Financial Metrics

Metric 2H 2025 2H 2024 12M 2025 12M 2024 YoY Change QoQ Change
Revenue (US\$’000) 30,817 24,787 55,187 43,842 +26% +24%
Gross Profit (US\$’000) 10,216 7,966 22,175 14,309 +55% +28%
Profit for the Period (US\$’000) 4,090 9,473 12,886 25,855 -50% -57%
EPS (Basic, US cents) 0.3 0.7 0.9 1.9 -52.6% -57.1%
Net Asset Value per Share (US cents) 6.50 5.51 6.50 5.51 +18% +18%
Dividend (per share) 0.175 S¢ (proposed) 0.047 S¢ (paid) 0.175 S¢ (proposed) 0.047 S¢ (paid) +272% N/A

Historical Performance Trends

  • Revenue: The Group saw a 26% YoY increase in revenue, driven mainly by shipyard activities (shipbuilding and repair) and stronger demand in ship chartering and management.
  • Gross Profit: Gross profit surged 55% YoY, reflecting higher-margin projects and improved vessel utilization.
  • Net Profit: Despite strong operational improvements, net profit fell 50% YoY due to one-off gains in 2024 not recurring in 2025 (notably, a US\$10.8 million gain from debt forgiveness in 2024 and other exceptional items).
  • Net Asset Value: NAV per share increased from 5.51 US cents to 6.50 US cents, signaling improved balance sheet strength.
  • Dividend: The board proposed a final dividend of 0.175 Singapore cents per share (approx. US\$2.0 million), up substantially from the previous year’s 0.047 S¢ (US\$547,000).

Exceptional Earnings and Expenses

  • 2024 profits included material one-off items: US\$10.8 million gain on debt forgiveness of bank loans, US\$4.3 million deferred gain on vessel sales, and US\$5.5 million write-back of impairment in an associate. These did not recur in 2025, explaining the sharp drop in reported net profit and EPS despite higher operational profitability.
  • In 2025, a non-cash fair value loss of US\$3.5 million was recognized due to the revaluation of derivative warrant liabilities, reflecting higher market prices for these instruments.
  • Write-back of impairment for property, plant, and equipment (US\$0.9 million) contributed positively to 2025’s results.

Divestments, Fundraising, and Warrant Conversions

  • During 2025, Pacific Radiance issued 7,225,424 new shares upon the conversion of warrants, raising US\$477,000 in new equity capital.
  • No major asset sales or IPOs were reported, but the company did realize a small gain (US\$150,000) from the sale of a joint venture investment.

Related-Party Transactions and Unusual Fund Flows

  • The company engaged in significant related-party transactions, particularly with joint ventures and associates, including charter hire, shipbuilding, and interest income.
  • Write-backs of amounts due from related companies were recognized, reflecting the repayment or settlement of these balances.

Macroeconomic and Industry Context

Management flagged increasing global uncertainty in 2H 2025, citing geopolitical tensions, evolving US trade policies, and a softer global energy demand outlook. While oil prices remained relatively stable, the Group sees ongoing volatility ahead, particularly due to potential supply disruptions and shifting policy environments. Offshore wind fundamentals remain robust, but investment is expected to focus on markets with high regulatory clarity, such as Europe and certain Asia-Pacific countries.

Chairman’s Statement

“The second half of 2025 was marked by a noticeable increase in global uncertainty, driven by escalating geopolitical tensions, shifting macroeconomic conditions and heightened policy unpredictability. This elevated uncertainty is expected to persist over the next 12 months… Given the fluid external environment, the Group will continue to exercise discipline in capital allocation and operational planning, while remaining positioned to capture opportunities across both the oil and gas and offshore wind markets.”

The tone is cautious, highlighting external risks but also emphasizing discipline and readiness to capitalize on sector opportunities.

Conclusion and Investor Recommendations

Overall, Pacific Radiance Ltd. delivered strong operational growth in 2025, with record revenues and gross profit. The underlying business performance improved significantly, but headline net profit fell due to the absence of 2024’s one-off gains and a non-cash loss from warrant revaluation. The company’s balance sheet strengthened, and management recommended a much higher dividend, signaling confidence in sustainable cash flows.

  • If you are currently holding the stock: The improvement in core operations, higher NAV, and a substantial increase in dividend payout support a hold recommendation. Investors may wish to monitor ongoing macroeconomic volatility and the fair value movement of warrant liabilities, but the company’s fundamentals have improved.
  • If you are not currently holding the stock: The rebound in operational earnings and higher dividend yield make Pacific Radiance a candidate for watch-listing or accumulating on dips. However, investors should be mindful of the company’s exposure to volatile sectors (offshore oil & gas, shipbuilding) and the potential impact of macro and policy risks.

Disclaimer: This analysis is based solely on the company’s published financial statements and does not constitute investment advice. Investors should consider their own risk tolerance and conduct further research or consult a professional before making investment decisions.

View Pacific RadianceW270919 Historical chart here



AsiaMedic Limited FY2025 Results: Revenue Grows 22%, No Dividend Declared Amid Expansion and Profit Surge

AsiaMedic Limited FY2025 Financial Results: Strong Growth Driven by Diagnostic Imaging Expansion AsiaMedic Limited has released its condensed interim consolidated financial statements for the full year ended 31 December 2025, demonstrating robust growth in...

Sri Trang Gloves (Thailand) 2025 Financial Statements and Auditor’s Report by EY – Revenue Recognition & Audit Highlights (No Dividend Details Provided)

Sri Trang Gloves (Thailand) PCL: FY2025 Audit Report Analysis Sri Trang Gloves (Thailand) Public Company Limited (STGT) has released its consolidated and separate financial statements for the year ended December 31, 2025. The financials...

Annaik Limited 1H2025 Financial Results: Profit Rises, Improved Gross Margins, Dividend Paid to PRC Subsidiaries 16

Annaik Limited 1H2025 Financial Results: Environmental Engineering Offsets Steel Weakness Annaik Limited has released its interim financial statements for the half-year ended 30 June 2025. The results highlight a resilient performance in the face...

   Ad